AMRI promotes Daniel Conlon to senior director of business development

Friday, September 14, 2012 12:51 PM

AMRI, a global contract research and manufacturing organization, has promoted Daniel Conlon to senior director of business development.

In this newly created role, Conlon will lead AMRI's development and manufacturing services sales team for North America. His responsibilities will include assisting with the strategic direction for generating sales in the North American territory and with the execution of revenue goals for his team.

Conlon's demonstrated knowledge and ability to sell AMRI's development and manufacturing services earned him the top sales position in 2012. Before joining AMRI in 2010, Conlon held a sales and management position with Merck, formally Organon BioSciences. He worked for Merck/Organon for eight years starting as a sales representative/district trainer. Following this role, he was promoted to district sales manager, overseeing a team across multistate districts.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 25

Verizon Communications enters clinical trial space with technology, network, and cloud and data services

Sponsors look to the power of genomic profiling to screen, enroll patients in trials for targeted therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs